Trial Profile
Pilot study of a dose-adjusted regimen of tiroban during percutnaeous coronary intervention
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 14 Jul 2014
Price :
$35
*
At a glance
- Drugs Tirofiban (Primary)
- Indications Acute coronary syndromes
- Focus Adverse reactions
- 14 Jul 2014 New trial record